Semaglutide improved MASLD in this population, and weight loss associated with its use resulted in no significant changes in physical function, according to two presentations at CROI.
The analysis of NHANES data found no evidence of an inverse association between dietary niacin intake and the risk for cardiovascular disease mortality.
ViiV Healthcare to present data for its next generation of ultra long-acting treatments for HIV pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Sustained efficacy was confirmed with an annualized relapse rate of 0.098 and 67% of patients were relapse-free at six years
Safety was consistent with prior findings and the established safety.
The investigational agent significantly improved liver biomarkers of disease activity and symptoms of pruritus in adults with PBC enrolled in a phase 3 trial.